Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

Recruiting Observational Study
Amyotrophic Lateral Sclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
180 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this project is to analyze the macrophage transcriptome and protein markers of Amyotrophic Lateral Sclerosis (ALS) patients compared to controls (non-affected individuals, patients with other motor impairments) and asymptomatic ALS gene carriers, to find new pathways for therapeutic targets and disease biomarkers.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Agree to participate in this research and have signed an informed consent * Be able to understand the objectives and procedures of the study * Be affiliated to French social security or equivalent * Meet one of the criteria below: (i) Be affected by Amyotrophic Lateral Scle…
Contacts

François SALACHAS, MD

+331 42 16 24 72

nathalie.cormand@aphp.fr

CONTACT

Severine BOILLEE, PhD

CONTACT